Geoffrey Lawrence is the managing director of drug policy at Reason Foundation.
Lawrence is also currently the chief financial officer of Claybourne, Co., a licensed cannabis company.
Lawrence has broad experience as a financial executive in the public and private sectors and a decade as a think tank analyst. Lawrence was previously Chief Financial Officer and Chief Compliance Officer at Players Network, Inc, the first fully reporting, publicly-traded marijuana company to be listed on a U.S. exchange. Lawrence oversaw all aspects of compliance with state and local laws and regulations for the licensed cultivation operations across two states.
Prior to that, Lawrence served as the senior appointee to the Nevada State Controller’s Office., where he oversaw external financial reporting, covering nearly $10 billion in annual transactions, on behalf of the state. During each year of Lawrence’s tenure, the state received the Certificate of Achievement for Excellence in Financial Reporting Award from the Government Finance Officers’ Association.
Lawrence spent a decade developing market-based solutions to challenges facing state governments while working at the Nevada Policy Research Institute and, previously, the John Locke Foundation in North Carolina. Lawrence has also written for the Cato Institute and the Heritage Foundation, with particular expertise in state budgets and labor economics.
Lawrence holds an M.A. in international economics from American University in Washington, D.C., an M.S. and a B.S. in accounting from Western Governors University, and a B.A. in international relations from the University of North Carolina at Pembroke.
Lower cannabis taxes could bolster Alaska’s legal market
Alaska's legal marijuana market could better compete with the black market if the state reduced its taxes.
Washington Senate Bill 5263 proposes important psilocybin reforms but could go further
The bill is a constructive proposal that lays the groundwork for the future adoption of a regulated marketplace for psilocybin in the state.
California Senate Bill 58 proposes constructive reforms but could go further in legalization of hallucinogenics
While the legalization of certain substances is a step in the right direction, the restrictions contained within the bill will result in a highly inefficient marketplace.
Comments and analysis of legal marijuana proposals and regulation in Hawaii’s SB 375 and SB 669
Reason Foundation recently offered testimony in Hawaii on how Senate Bill 375 and Senate Bill 669 would impact the cannabis industry.
Three common mistakes in cannabis legalization proposals this year
More than a dozen states are currently considering legalizing medical marijuana or adult-use cannabis.
Testimony: Cannabis labor peace mandate in Minnesota HF 100 violates federal law
There is a long series of legal precedents that make clear proposals contained within House File 100 would be deemed federally unconstitutional.
Florida bureaucrats again stymie state’s legal medical marijuana market
Florida’s politicians should stop using red tape, fees, and bureaucracy to block businesses that want to provide legally prescribed medication to patients in need.
Nikki Fried is right to sue for medical marijuana patients’ gun rights
Regulations against gun ownership for medical marijuana patients violate those patients’ Second Amendment rights.
Comments on Oregon’s proposed psilocybin services rules
Overall, the process appears to have generated a prudent set of rules that would create a program that balances client safety with strong licensee oversight under a flexible set of program rules.